BioCina News and Resources

BioCina, a global contract development and manufacturing organisation (CDMO), has announced a strategic merger with NovaCina. The merger integrates both companies’ expertise to deliver a seamless suite of end-to-end manufacturing solutions for the biopharmaceutical and small molecule industries. The new

BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), has announced a partnership with Centivax, Inc. The collaboration aims to develop Centivax’s universal influenza vaccine, Cent-Flu, which utilises a proprietary mixture of 22 unique mRNA transcripts

BioCina Pty Ltd., a global biologics Contract Development and Manufacturing Organization (CDMO), has announced a partnership with drug developer EnGeneIC Pty Ltd. This collaboration focuses on the technology transfer, process scale-up, and GMP batch manufacture of EnGeneIC’s proprietary ‘EnGeneIC Dream